Go back to sleep.
It is an update on a ongoing phase 2 trial with a cancer that has no other treatment options.
The Dignity trial may lead to a fda approval sooner rather than later.
12 evaluable patients, notably 5 complete responses, 2 partial responses (:PR) and 1 patient with stable disease.
I suppose its a small market, but they won't be charging $5. The beauty is that they don't need to charge a life changing amount of money to have a life changing impact and to produce significant value . Just assume 10k a year is treated and there is significant value. At then end of the day, maybe this is just a "small cap" company, which means in worth 20x its current value.
Didn’t think it was possible to pick winners so consistently. Good thing I found Ultimate Stock Alerts (look them up in Google). Made back my all my losses in a week!
It's a day trader thing. Watch that $3 level, all traders start exiting at once. EOD also could hurt.
On the other hand. It's great news for the resistant chest wall patient, a very very small market.
And a WHOLE LOT of haters were created on Feb 20............at the last Pop&Drop Press Release.
Check it out !
Traders having fun today. All exit at EOD may give you the stock back at $250 today. Tiny study and results were expected for chest wall. If it threatens to lose $3 traders should flee ASAP.
Shares Outstanding: 19.98M
% Held by Insiders1: 26.34%
% Held by Institutions1: 16.70%
Total Cash (mrq): 36.86M
You can bet on it !
Company is now looking to hire new Press Release writers.
Academy Award worthy Press Releases.
bioandsense....You have to do just a little more DD than their current Press Release.
This is a Press Release company.
Gee the drop isn't even waiting until the end of the day this time..........looks like more people know about this one already.